DYSLIPIDEMIA IN INDIVIDUALS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: PATHOPHYSIOLOGY, CLINICAL IMPLICATIONS, AND MANAGEMENT

Dyslipidemia, characterized by abnormal lipid profiles, is frequently observed in individuals with chronic obstructive pulmonary disease (COPD). This condition has gained attention due to its potential impact on the progression of COPD and its association with increased cardiovascular morbidity and mortality. The mechanisms linking dyslipidemia to COPD are multifactorial, involving systemic inflammation, oxidative stress, and alterations in lipid metabolism. These changes may exacerbate the underlying pulmonary pathology and contribute to the higher cardiovascular risk seen in COPD patients. This review examines the pathophysiological mechanisms, clinical significance, and potential therapeutic strategies to address dyslipidemia in the context of COPD. Emphasis is placed on the importance of early detection, monitoring of lipid profiles, and the role of lipid-modifying agents in improving patient outcomes.